Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Cancer Diagnostics Market size was over USD 113.89 billion in 2024 and is poised to exceed USD 248.95 billion by 2037, growing at over 6.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of cancer diagnostics is estimated at USD 119.89 billion.
This can be attributed to the rising incidence of cancer among people and inadequate medical infrastructure of middle and low income countries. According to World Health Organization, cancer is the second leading cause of death globally with 70% of the total deaths occurring in low and middle income countries.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of cancer diagnostics is estimated at USD 119.89 billion.
Cancer Diagnostics Market size was over USD 113.89 billion in 2024 and is poised to exceed USD 248.95 billion by 2037, growing at over 6.2% CAGR during the forecast period i.e., between 2025-2037.
North America industry is anticipated to account for largest revenue share by 2037, backed by increasing geriatric population, rising research and development initiatives by the government, increasing cancer cases among the population and need for evidence based treatment for cancer.
The major players in the market are Siemens Healthcare Gmbh, GE Healthcare, Abbott, Becton, Dickinson & Company, Illumina Inc., Hologic Inc., F.Hoffman-La Roche, Qiagen NV, Phillips Healthcare, CR Bard Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., Biocartis SA, Biocare Medical LLC, Cancer Genetics Inc., Myriad Genetics, and others.
